The central government has so far earmarked ₹50,000 crore — from its own resources — for the Covid-19 vaccine programme. The Oxford AstraZeneca candidate would fit the bill perfectly.(Bloomberg file photo. Representative image)
The central government has so far earmarked ₹50,000 crore — from its own resources — for the Covid-19 vaccine programme. The Oxford AstraZeneca candidate would fit the bill perfectly.(Bloomberg file photo. Representative image)

Coronavirus: India in talks with global vaccine manufacturers

The officials working for the Union government maintained that all vaccines will be considered for uptake, and Pfizer as well as Moderna’s announcements that their vaccine candidates were 90% and 94.5% successful, respectively, in phase 3 clinical trials prompted India to recalibrate its options.
By Saubhadra Chatterji and Sunetra Chowdhury | Hindustan Times, New Delhi
UPDATED ON NOV 17, 2020 03:06 AM IST

India is in talks with Pfizer, Moderna and other manufacturers for a possible deal to purchase a coronavirus disease (Covid-19) vaccine as rising infections pose a challenge to the country’s health authorities, officials familiar with the matter said on Monday.

The officials working for the Union government maintained that all vaccines will be considered for uptake, and Pfizer as well as Moderna’s announcements that their vaccine candidates were 90% and 94.5% successful, respectively, in phase 3 clinical trials prompted India to recalibrate its options.

A senior official of the Centre’s team of experts on the vaccine said, “We are mindful of the prices, the cost factor is a profound concern to us”.

Last month, Pfizer and its German partner BioNTech said their vaccine would be priced at $19.50 a dose, a steep difference from the Oxford AstraZeneca candidate that is expected to carry a price tag of below two dollars apiece. Moderna, the other front runner, has pegged its doses between $32 and $37 a dose.

Also Read| Covid-19: Bharat Biotech begins Phase 3 trials of Covaxin in India

To be sure, two officials from the expert group insisted that no agreement has been made with Pfizer or Moderna or even for Moscow’s Sputnik V so far but talks are on with all possible candidates.

“We are in touch with all manufacturers, both domestic and international. To provide access to vaccine to our people at the earliest, we have to keep in mind the entire landscape. While Indian vaccines are promising, some other candidates are ahead in the race. We are closely watching all developments. But affordability is critical and important,’’ said a member of the group.

Another member said recent news of the EU striking a deal with Pfizer and BioNTech for securing 200 million doses but at a lower price than the US has also caught the group’s attention and a bargain is not being ruled out.

“We will secure vaccines from every possible source. While our own vaccines are still in the race, some vaccines are near the finishing line. If we want quick procurements, we have no option but to negotiate with them.”

Also Read: A tipping point in the fight against Covid-19

The central government has so far earmarked 50,000 crore — from its own resources — for the Covid-19 vaccine programme. The Oxford AstraZeneca candidate would fit the bill perfectly.

Niti Aayog member Dr VK Paul, chairman of the expert group, said, “We are keeping an open watch on vaccine developments nationally and internationally, with the goal of ensuring that we have access to a safe and effective vaccine at the earliest to the maximum possible people.’’

“We can expect a vaccine early 2021 — the first quarter of the year,” he said.

SHARE THIS ARTICLE ON
app
Close
Researchers also say that the evolution of Sars-Cov-2 at present does not pose a major risk since the changes seen even till now do not make existing immunity (from older infections) or vaccines completely obsolete.(REUTERS)
Researchers also say that the evolution of Sars-Cov-2 at present does not pose a major risk since the changes seen even till now do not make existing immunity (from older infections) or vaccines completely obsolete.(REUTERS)

Covid: South African, Brazilian strains raise new fears on vaccines, immunity

PUBLISHED ON JAN 21, 2021 04:43 AM IST
The first major mutation of the Sars-Cov-2 virus was reported from the UK in the so-called B.1.1.7 variant (also called VOC202012/01) ; authorities said in December that it was more infectious, and it was later seen as a factor in leading to the country’s worst wave yet.
Close
Bharat Biotech developed Covaxin in collaboration with the Indian Council of Medical Research.(REUTERS)
Bharat Biotech developed Covaxin in collaboration with the Indian Council of Medical Research.(REUTERS)

Covaxin recipients to be monitored for three months after second dose

UPDATED ON JAN 21, 2021 04:38 AM IST
If a serious adverse event is linked to vaccination, then the recipient will be compensated based on the national drug controller’s recommendations after thorough investigation, said the plan.
Close
Former Congress president Rahul Gandhi is widely preferred within the party to replace Sonia Gandhi as efforts to pick a non-Gandhi party president have not succeeded in the past two years ago.(Sonu Mehta/HT PHOTO)
Former Congress president Rahul Gandhi is widely preferred within the party to replace Sonia Gandhi as efforts to pick a non-Gandhi party president have not succeeded in the past two years ago.(Sonu Mehta/HT PHOTO)

Congress Working Committee meet on Jan 22 with eye on party polls

PUBLISHED ON JAN 21, 2021 04:32 AM IST
“It will be a meeting of the full CWC,” a senior Congress leader said on condition of anonymity. The meet will include 19 members, 26 permanent invitees and nine special invitees other than the Congress president.
Close
MSMEs employ about 110 million workers and contribute to about 40% of exports (MSME census, 2006-07), and have a huge role to play in creating quality jobs, improving export competitiveness, and increasing aggregate productivity.(Sunil Ghosh/HT file photo. Representative image)
MSMEs employ about 110 million workers and contribute to about 40% of exports (MSME census, 2006-07), and have a huge role to play in creating quality jobs, improving export competitiveness, and increasing aggregate productivity.(Sunil Ghosh/HT file photo. Representative image)

Need focus on removing obstacles to ‘good’ jobs

By hindustantimes.com
PUBLISHED ON JAN 21, 2021 04:25 AM IST
As businesses struggled to stay afloat, the government announced a number of measures targeted towards the so-called Micro, Small and Medium Enterprises (MSMEs). Many of these measures, part of the Atmanirbhar Bharat Abhiyan package, are aimed at easing financial constraints faced by businesses.
Close
A medical worker (R) inoculates a medical staff with a Covid-19 Coronavirus vaccine at the Manipal Hospital, in New Delhi on January 19, 2021.(AP)
A medical worker (R) inoculates a medical staff with a Covid-19 Coronavirus vaccine at the Manipal Hospital, in New Delhi on January 19, 2021.(AP)

Covid-19 vaccine doses wasted in more states over hesitancy

By HT Correspondent, New Delhi/patna/chennai/rohtak
UPDATED ON JAN 21, 2021 04:07 AM IST
India’s start to the Covid-19 vaccination programme has been one of the strongest in the world, reaching more people on its first day than any other country.
Close
Gandhi’s 16-feet high bronze statue in a meditating posture, sculpted by Ram Sutar, was unveiled by then President Shanker Dayal Sharma on October 2, 1993.(ANI Photo)
Gandhi’s 16-feet high bronze statue in a meditating posture, sculpted by Ram Sutar, was unveiled by then President Shanker Dayal Sharma on October 2, 1993.(ANI Photo)

New Parliament building: Gandhi statue hurriedly shifted, move raises eyebrows

PUBLISHED ON JAN 21, 2021 12:55 AM IST
Initial plan was to do so during the one-month gap between the first and the second part of Budget Session that begins on Jan 29
Close
HT Image
HT Image

CBI arrests two of its officials in Bribery case

By Neeraj Chauhan
PUBLISHED ON JAN 21, 2021 12:15 AM IST
New Delhi: The Central Bureau of Investigation (CBI) has arrested its deputy superintendent of police (DSP), R K Rishi, inspector Kapil Dhankad and an advocate Manohar Malik in connection with its probe into a “bribes-for-relief” scandal in the agency, people familiar with the development said on Wednesday
Close
HT Image
HT Image

SC irked over criticism of farm committee picks

PUBLISHED ON JAN 21, 2021 12:15 AM IST
The Supreme Court on Wednesday strongly defended its choice of members for the committee that will weigh in on the contentious farm laws, and cautioned critics against attributing motives to the court or “maligning” members of the panel just because they had in the past come out in favour of these legislation aimed at opening up farm markets
Close
HT Image
HT Image

Electoral rolls, not NRC, to determine voters in Assam: EC

PUBLISHED ON JAN 21, 2021 12:14 AM IST
GUWAHATI: The Election Commission of India (ECI) made it clear on Wednesday that those living in Assam whose names are missing from the updated National Register of Citizens (NRC), but are listed in the electoral rolls can vote in the assembly elections due in April-May this year
Close
HT Image
HT Image

‘Goli Maaro’ chants at BJP leader Suvendu’s rally in Bengal

UPDATED ON JAN 21, 2021 12:14 AM IST
Kolkata Supporters of the Bharatiya Janata Party on Wednesday allegedly raised the controversial “goli maaro” slogan at a roadshow in West Bengal’s Hooghly district, a day after a similar slogan was raised by supporters of the ruling Trinamool Congress
Close
HT Image
HT Image

After cabinet expansion, dissent brews in Karnataka BJP

By Sharan Poovanna
UPDATED ON JAN 21, 2021 12:13 AM IST
Bengaluru: Troubles are mounting for Karnataka chief minister B
Close
HT Image
HT Image

One in 3 new Covid cases recorded in Kerala

PUBLISHED ON JAN 21, 2021 12:11 AM IST
Thiruvananthapuram: More than one in every three new Covid-19 cases recorded in India over the last week have come from Kerala, a state that is defying the national trend of falling infections and has been the biggest outbreak centre in the country since late October
Close
HT Image
HT Image

Covaxin recipients to be monitored for three months after 2nd dose

UPDATED ON JAN 21, 2021 12:10 AM IST
New Delhi Covaxin recipients will be monitored for three months after getting the 2nd dose for any adverse reactions, according to a detailed plan released by the Indian Council of Medical Research (ICMR) in an attempt to dispel safety concerns about the vaccine whose efficacy data isn’t publicly known
Close
HT Image
HT Image

SA, Brazil strains raise new fears on vaccines, immunity

By Binayak Dasgupta, New Delhi
PUBLISHED ON JAN 21, 2021 12:09 AM IST
Mutations of the Sars-Cov-2 virus found in South Africa and Brazil have begun worrying authorities and scientists who say that these – they are distinct from the new variant first found in the UK – could trigger more re-infections, even reduce vaccine efficacy, though more tests are underway
Close
Loyalists and detractors alike await the release of Sasikala, who once kept the ruling AIADMK under her thumb.(HT PHOTO)
Loyalists and detractors alike await the release of Sasikala, who once kept the ruling AIADMK under her thumb.(HT PHOTO)

Sasikala hospitalised in Bengaluru week before her release from prison

PUBLISHED ON JAN 21, 2021 12:08 AM IST
  • Sixty-three-year-old Sasikala who also suffers from hypertension, diabetes and hypothyroidism was admitted to hospital with cough and fever.
Close
SHARE
Story Saved
OPEN APP